There is no market for new antibiotics: this allows an open approach to research and development [version 1; peer review: 2 approved]
There is an increasingly urgent need for new antibiotics, yet there is a significant and persistent economic problem when it comes to developing such medicines. The problem stems from the perceived need for a “market” to drive commercial antibiotic development. In this article, we explore abandoning...
Main Authors: | Dana M. Klug, Fahima I. M. Idiris, Mark A. T. Blaskovich, Frank von Delft, Christopher G. Dowson, Claas Kirchhelle, Adam P. Roberts, Andrew C. Singer, Matthew H. Todd |
---|---|
Format: | Article |
Language: | English |
Published: |
Wellcome
2021-06-01
|
Series: | Wellcome Open Research |
Online Access: | https://wellcomeopenresearch.org/articles/6-146/v1 |
Similar Items
-
Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections [version 1; peer review: 2 approved]
by: Andrew C. Singer, et al.
Published: (2019-03-01) -
Open science approaches to COVID-19 [version 1; peer review: 2 approved]
by: Edwin G. Tse, et al.
Published: (2020-08-01) -
Pyrrhic Progress : The History of Antibiotics in Anglo-American Food Production
by: Kirchhelle, Claas
Published: (2020) -
Editorial: The Need for Harmonised International Guidelines ahead of COVID-19 Human Infection Studies
by: Claas Kirchhelle, et al.
Published: (2021-01-01) -
Feasibility of informing syndrome-level empiric antibiotic recommendations using publicly available antibiotic resistance datasets [version 2; peer review: 2 approved, 1 approved with reservations]
by: Quentin J. Leclerc, et al.
Published: (2020-06-01)